Halank M - Search Results

1

Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study.

Valerio L, Mavromanoli AC, Barco S, Abele C, Becker D, Bruch L, Ewert R, Faehling M, Fistera D, Gerhardt F, Ghofrani HA, Grgic A, Grünig E, Halank M, Held M, Hobohm L, Hoeper MM, Klok FA, Lankeit M, Leuchte HH, Martin N, Mayer E, Meyer FJ, Neurohr C, Opitz C, Schmidt KH, Seyfarth HJ, Wachter R, Wilkens H, Wild PS, Konstantinides SV, Rosenkranz S; FOCUS Investigators. Valerio L, et al. Among authors: halank m. Eur Heart J. 2022 Sep 21;43(36):3387-3398. doi: 10.1093/eurheartj/ehac206. Eur Heart J. 2022. PMID: 35484821 Free PMC article.

2

[Severe precapillary pulmonary hypertension in possible antiphospholipid syndrome--partially successful long-term therapy with continuous intravenous iloprost administration. A case report with discussion of new treatment methods].

Halank M, Rubens C, Ewert R, Höffken G, Braun J. Halank M, et al. Z Rheumatol. 2000 Oct;59(5):334-42. doi: 10.1007/s003930070056. Z Rheumatol. 2000. PMID: 11142929 German.

3

Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension.

Rubens C, Ewert R, Halank M, Wensel R, Orzechowski HD, Schultheiss HP, Hoeffken G. Rubens C, et al. Among authors: halank m. Chest. 2001 Nov;120(5):1562-9. doi: 10.1378/chest.120.5.1562. Chest. 2001. PMID: 11713135

4

[Sildenafil in pulmonary hypertension].

Ewert R, Höper M, Halank M, Winkler J, Wensel R, Opitz C. Ewert R, et al. Among authors: halank m. Pneumologie. 2003 May;57(5):291; author reply 291-2; discussion 292. Pneumologie. 2003. PMID: 12825577 German. No abstract available.

5

Long term survival in primary pulmonary hypertension.

Halank M, Marx C, Hoeffken G. Halank M, et al. Heart. 2004 Jul;90(7):e40. doi: 10.1136/hrt.2004.035725. Heart. 2004. PMID: 15201266 Free PMC article.

6

Low frequency of BMPR2 mutations in a German cohort of patients with sporadic idiopathic pulmonary arterial hypertension.

Koehler R, Grünig E, Pauciulo MW, Hoeper MM, Olschewski H, Wilkens H, Halank M, Winkler J, Ewert R, Bremer H, Kreuscher S, Janssen B, Nichols WC. Koehler R, et al. Among authors: halank m. J Med Genet. 2004 Dec;41(12):e127. doi: 10.1136/jmg.2004.023101. J Med Genet. 2004. PMID: 15591269 Free PMC article. No abstract available.

7

Bosentan therapy for portopulmonary hypertension.

Hoeper MM, Halank M, Marx C, Hoeffken G, Seyfarth HJ, Schauer J, Niedermeyer J, Winkler J. Hoeper MM, et al. Among authors: halank m. Eur Respir J. 2005 Mar;25(3):502-8. doi: 10.1183/09031936.05.00080804. Eur Respir J. 2005. PMID: 15738295 Free article.

8

Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension.

Opitz CF, Wensel R, Winkler J, Halank M, Bruch L, Kleber FX, Höffken G, Anker SD, Negassa A, Felix SB, Hetzer R, Ewert R. Opitz CF, et al. Among authors: halank m. Eur Heart J. 2005 Sep;26(18):1895-902. doi: 10.1093/eurheartj/ehi283. Epub 2005 May 11. Eur Heart J. 2005. PMID: 15888496

9

[Assessment of cardiopulmonary function at rest and during exercise in patients with pulmonary hypertension].

Ewert R, Opitz CF, Wensel R, Halank M, Winkler J, Lodziewski S, Felix SB. Ewert R, et al. Among authors: halank m. Herz. 2005 Jun;30(4):318-25. doi: 10.1007/s00059-005-2690-9. Herz. 2005. PMID: 15965809 Review. German.

10

[A role for combination therapy in pulmonary arterial hypertension].

Behr J, Borst MM, Winkler J, Hoeper M, Halank M, Ghofrani A, Klose H, Wilkens H, Stähler G. Behr J, et al. Among authors: halank m. Pneumologie. 2005 Oct;59(10):730-5. doi: 10.1055/s-2005-915556. Pneumologie. 2005. PMID: 16222588 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page